(Q33750616)

English

Paroxetine Controlled Release for Premenstrual Dysphoric Disorder: Remission Analysis Following a Randomized, Double-Blind, Placebo-Controlled Trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Paroxetine Controlled Release for Premenstrual Dysphoric Disorder: Remission Analysis Following a Randomized, Double-Blind, Placebo-Controlled Trial (English)

1 reference

Europe PubMed Central

29 July 2017

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

author name string

Teri B Pearlstein

1

1 reference

Europe PubMed Central

29 July 2017

Kevin M Bellew

2

1 reference

Europe PubMed Central

29 July 2017

Jean Endicott

3

1 reference

Europe PubMed Central

29 July 2017

Meir Steiner

4

1 reference

Europe PubMed Central

29 July 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

29 July 2017

Primary Care Companion to the Journal of Clinical Psychiatry

1 reference

Europe PubMed Central

29 July 2017

7

1 reference

Europe PubMed Central

29 July 2017

53-60

1 reference

Europe PubMed Central

29 July 2017

2

1 reference

Europe PubMed Central

29 July 2017

Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

21 June 2018

Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

21 June 2018

Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

21 June 2018

Is premenstrual dysphoric disorder a distinct clinical entity?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

21 June 2018

Mental disorders and disability among patients in a primary care group practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

21 June 2018

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

21 June 2018

A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

21 June 2018

The measurement of disability.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

21 June 2018

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

21 June 2018

Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

21 June 2018

Clinical applications of visual analogue scales: a critical review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

21 June 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

21 June 2018

Severity of premenstrual symptoms in a health maintenance organization population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

30 October 2018

Prevalence, incidence and stability of premenstrual dysphoric disorder in the community

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

30 October 2018

Premenstrual symptom severity: impact on social functioning and treatment-seeking behaviors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

30 October 2018

Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

30 October 2018

Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079696

30 October 2018

The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France

1 reference

https://pubmed.ncbi.nlm.nih.gov/15841196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The measurement of premenstrual mood symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/15841196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late luteal phase dysphoric disorder in young women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15841196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15841196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15841196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4088/PCC.V07N0203

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33750616&oldid=1534234890"